Company research / MREO

Mereo BioPharma Group plc (MREO)

Build a valuation ↗↓ Download CSV

CIK 0001719714 · Nasdaq · Pharmaceutical Preparations

Sector Manufacturing
Incorporated X0
Fiscal year ends Dec 31

For the year ended 2025-12-31, Mereo BioPharma Group plc reported revenue of $500.0K.

Key ratios (year ended 2025-12-31)

-8021.4%

Operating margin

-8375.6%

Net margin

-102.4%

Return on year-end equity

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: 8-K · 2026-08-19

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. A dash means a matching observation is unavailable.

Period ended	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Revenue	$500.0K	$0	$10.00M	$0	—
Operating Income	-$40.11M	-$47.36M	-$28.42M	-$54.43M	—
Net Income	-$41.88M	-$43.25M	-$29.47M	-$42.22M	—
EPS (Diluted)	$-0.05	$-0.06	$-0.04	$-0.07	—
Total Assets	$45.92M	$76.39M	$66.50M	$77.41M	—
Total Liabilities	$5.00M	$15.42M	$15.96M	$26.01M	—
Shareholders' Equity	$40.92M	$60.97M	$50.54M	$51.40M	$92.20M
Cash & Equivalents	$40.99M	$69.80M	$57.42M	$68.18M	—
Operating Cash Flow	-$30.97M	-$32.83M	-$21.13M	-$48.82M	—
Capital Expenditures	$20.0K	$0	$0	$13.0K	—
Weighted Average Diluted Shares	797.12M	739.62M	659.45M	603.20M	—
EPS (Basic)	$-0.05	$-0.06	$-0.04	$-0.07	—